Biocon Biologics
Adalimumab Immunology & rheumatology
Originator: Humira · AbbVie (originally developed and marketed by Abbott Laboratories; initial U.S. approval 2002)
| Brand | Strength | Form | Unit price | ≈ USD | Pack |
|---|---|---|---|---|---|
| Adalimumab-fkjp (marketed as Hulio in some markets) | 40 mg/0.4 mL and 40 mg/0.8 mL pen/prefilled syringe | — | — | — | — |
Bevacizumab Cancer (oncology)
Originator: Avastin · Genentech, Inc. / F. Hoffmann-La Roche Ltd
| Brand | Strength | Form | Unit price | ≈ USD | Pack |
|---|---|---|---|---|---|
| Krabeva (India); Abevmy (EU/Canada); Jobevne (US) | 100 mg/4 mL and 400 mg/16 mL | — | — | — | — |
Insulin Aspart Diabetes & metabolic
Originator: NovoRapid · Novo Nordisk
| Brand | Strength | Form | Unit price | ≈ USD | Pack |
|---|---|---|---|---|---|
| Kirsty (insulin aspart-xjhz) in the US; Kixelle in the EU | 100 units/mL (U-100) solution for injection | — | — | — | — |
Insulin Glargine Diabetes & metabolic
Originator: Lantus · Sanofi
| Brand | Strength | Form | Unit price | ≈ USD | Pack |
|---|---|---|---|---|---|
| Semglee (insulin glargine-yfgn); also unbranded insulin glargine-yfgn | 100 IU/mL, 3 mL prefilled pen and vial | — | — | — | — |
Trastuzumab Cancer (oncology)
Originator: Herceptin · Genentech, Inc. / F. Hoffmann-La Roche Ltd
| Brand | Strength | Form | Unit price | ≈ USD | Pack |
|---|---|---|---|---|---|
| Canmab (India); Hertraz (India, co-exclusive with Mylan); Ogivri (US, EU, Malaysia as Zuhera) | 150 mg and 440 mg vials | — | — | — | — |
This page is an information resource for healthcare professionals, licensed importers and patients under medical care. It is not medical advice, not a prescription service, and not an offer to sell prescription medicines to the public.
Need a verified quotation?
Send us the molecule, strength, pack size, quantity and destination country. We reply with a batch-traceable quotation, certificates of analysis and shipping documentation.
We supply licensed pharmacies, hospitals, importers and distributors — not direct-to-consumer patients.